Filing Flows › Ceribell (CBLL) › Q2 2026 › vs Q2 2025
Ceribell (CBLL) Q2 2026 vs Q2 2025 (year over year)
Ceribell's revenue rose $6.9M (+33%) from $21.2M in Q2 2025 to $28.1M in Q2 2026. The biggest changes: Product +$5.3M (+33%); Subscription +$1.6M (+30%).
Ceribell, Q2 2026: revenue $28.1M (+32% year over year), operating margin -71.1%, net loss $19.3M, operating cash flow −$12.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $21.2M | $15.9M | $5.3M | +33% |
| Subscription | $6.9M | $5.3M | $1.6M | +30% |
| Revenue | $28.1M | $21.2M | $6.9M | +33% |
| Other income, net | $713K | $1.3M | −$596K | -46% |
| Net loss | $19.3M | $13.6M | $5.6M | +41% |
| Costs & expenses | $48.1M | $36.2M | $11.9M | +33% |
| Operating costs | $48.1M | $36.2M | $11.9M | +33% |
| Cost of revenue | $2.2M | $2.5M | −$358K | -14% |
| Research & development | $6.7M | $4.9M | $1.9M | +39% |
| Sales & marketing | $24.4M | $17.4M | $7.0M | +40% |
| General & admin | $14.8M | $11.4M | $3.4M | +30% |
| Operating cash sources | $19.3M | $13.6M | $5.6M | +41% |
| Depreciation & amortization | $245K | $324K | −$79K | -24% |
| Share-based compensation | $6.0M | $3.2M | $2.8M | +89% |
| Working capital & other | $162K | $2.6M | −$2.5M | -94% |
| Cash used in operations | $12.9M | $7.5M | $5.3M | +71% |
| Net loss absorbed | $19.3M | $13.6M | $5.6M | +41% |
Questions
How much did Ceribell's revenue grow year over year in Q2 2026?
Ceribell's revenue rose $6.9M (+33%) from $21.2M in Q2 2025 to $28.1M in Q2 2026.
What drove Ceribell's revenue change in Q2 2026?
Product +$5.3M (+33%); Subscription +$1.6M (+30%).